Completed PHASE4 INTERVENTIONAL 1-arm NCT00244270

Cystic Fibrosis and Totally Implantable Vascular Access Devices (RITHM)

Cystic Fibrosis and Totally Implantable Vascular Access Devices: Evaluation of the Incidence of Venous Thrombosis Related to the Catheter and Study of the Genetic and Acquired Risk Factors

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Cystic Fibrosis Venous Thrombosis

Interventions totally implantable vascular access device

Updated 5 times since 2017 Last updated: Aug 26, 2011 Started: Dec 31, 2005 Primary completion: Mar 31, 2009 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cystic Fibrosis and Venous Thrombosis, this trial is completed. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris
Vaincre la Mucoviscidose

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.